TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 DKK)
| Closing information | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Turnover |
16,600
|
13,958
|
22,951 |
| Financial expenses |
117
|
162
|
136 |
| Earnings before taxes |
-1,216
|
-2,189
|
217 |
| EBITDA |
-624
|
-1,489
|
1,489 |
| Total assets |
14,097
|
15,326
|
14,428 |
| Current assets |
10,141
|
11,004
|
9,519 |
| Current liabilities |
3,619
|
3,916
|
2,439 |
| Equity capital |
9,549
|
9,370
|
9,016 |
| - share capital |
138
|
135
|
130 |
| Employees (average) |
25
|
29
|
34 |
Financial ratios
| Fiscal year | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Solvency |
67.7%
|
61.1%
|
62.5% |
| Turnover per employee |
664
|
481
|
675 |
| Profit as a percentage of turnover |
-7.3%
|
-15.7%
|
0.9% |
| Return on assets (ROA) |
-7.8%
|
-13.2%
|
2.4% |
| Current ratio |
280.2%
|
281.0%
|
390.3% |
| Return on equity (ROE) |
-12.7%
|
-23.4%
|
2.4% |
| Change turnover |
2,369
|
-9,901
|
5,093 |
| Change turnover % |
17%
|
-41% | |
| Chg. No. of employees |
-4
|
-5
|
32 |
| Chg. No. of employees % |
-14%
|
-15% |
Total value of public sale
| Fiscal year | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.